Gibson Christopher sold RXRX
September 10, 2025 · Form 4 insider transaction
Gibson Christopher sold 100,000 shares of Recursion Pharmaceuticals, Inc. at $4.71 per share, a transaction worth $471.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100,000
Price
$4.71
Total value
$471.0K
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 10, 2025
Filing dateSeptember 12, 2025
Shares owned after974,229
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.